Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001933414-25-000046

CFO and Secretary sold 10,757 shares at $12.06 ($129,684)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Levy Adam Scott CFO and Secretary 2025-04-11 Sale 10b5-1 −10,757 $12.06 $129,684 215,340 D
Open-market sales · 10,757 sh · avg $12.06 · $129,684
Loading xslF345X05/wk-form4_1744763754.xml…